Ann: Neuren appoints Joe Horrigan VP Clinical and, page-7

re: Ann: Neuren appoints Joe Horrigan VP Clin... A pretty impressive appointment because it strengthens Neus chances of securing further non-dilutionary funding through competative grant funding sources.

This is because Horrigan as a grant funder in his own right knows what makes for an attractive funding application.

Or if you are more cynical - given his clout in terms of controlling the purse strings around one major funding area and his editorial roles in the best journals - means he will get a bit of an easier run through peer review.

Either way - its a very good move by Neu in terms of attracting further funding to progress its work imo.